Literature DB >> 32446214

Staging and grading of oral squamous cell carcinoma: An update.

Alhadi Almangush1, Antti A Mäkitie2, Asterios Triantafyllou3, Remco de Bree4, Primož Strojan5, Alessandra Rinaldo6, Juan C Hernandez-Prera7, Carlos Suárez8, Luiz P Kowalski9, Alfio Ferlito10, Ilmo Leivo11.   

Abstract

Oral squamous cell carcinoma (OSCC) is a common malignancy of the head and neck region. OSCC has a relatively low survival rate and the incidence of the disease is increasing in some geographic areas. Staging and grading of OSCC are established prerequisites for management, as they influence risk stratification and are the first step toward personalized treatment. The current AJCC/UICC TNM staging (8th edition, 2017) of OSCC has included significant modifications through the incorporation of depth of invasion in the T stage and extracapsular spread/extranodal extension in the N stage. Further modifications for AJCC 8 have been suggested. On the other hand, the World Health Organization (WHO) classification (4th edition, 2017) still endorses a simple, differentiation-based histopathologic grading system of OSCC (despite its low prognostic value) and ignores factors such as tumor growth pattern and dissociation, stromal reactions (desmoplasia, local immune response), and tumor-stroma ratio. The various controversies and possible developments of the current staging and grading criteria of OSCC are briefly discussed in this update together with possible applications of artificial intelligence in the context of screening and risk stratification.
Copyright © 2020 The Authors. Published by Elsevier Ltd.. All rights reserved.

Entities:  

Keywords:  Grading; Oral squamous cell carcinoma (OSCC); Prognosis; Staging

Mesh:

Year:  2020        PMID: 32446214     DOI: 10.1016/j.oraloncology.2020.104799

Source DB:  PubMed          Journal:  Oral Oncol        ISSN: 1368-8375            Impact factor:   5.337


  36 in total

1.  PSMC2 knockdown inhibits the progression of oral squamous cell carcinoma by promoting apoptosis via PI3K/Akt pathway.

Authors:  Zijia Wang; Haofeng Xiong; Yijie Zuo; Shujun Hu; Chao Zhu; Anjie Min
Journal:  Cell Cycle       Date:  2022-01-04       Impact factor: 4.534

2.  Metabolomic Analysis Reveals that SPHK1 Promotes Oral Squamous Cell Carcinoma Progression through NF-κB Activation.

Authors:  Chen-Xing Hou; Guang-Yan Mao; Qiu-Wangyue Sun; Ying Meng; Qing-Hai Zhu; Yu-Ting Tang; Wei Han; Nan-Nan Sun; Xiao-Meng Song; Chen-Xing Wang; Jin-Hai Ye
Journal:  Ann Surg Oncol       Date:  2022-07-12       Impact factor: 4.339

3.  An Immune-Related Gene Signature Can Predict Clinical Outcomes and Immunotherapeutic Response in Oral Squamous Cell Carcinoma.

Authors:  Liyuan Zhang; Xiaopeng Wang
Journal:  Front Genet       Date:  2022-07-04       Impact factor: 4.772

4.  LINC01116 Promotes Migration and Invasion of Oral Squamous Cell Carcinoma by Acting as a Competed Endogenous RNA in Regulation of MMP1 Expression.

Authors:  Yukang Ying; Dong Liu; Yue Zhao; Yuan Zhong; Xuhui Xu; Jun Luo; Zhenxing Zhang
Journal:  Comput Math Methods Med       Date:  2022-06-17       Impact factor: 2.809

Review 5.  Expression of Sex Hormones in Oral Squamous Cell Carcinoma: A Systematic Review on Immunohistochemical Studies.

Authors:  Saranya R; Chandini R; Khadijah Mohideen; Pooja N Adtani; Vijayanirmala Subramani; Murali Balasubramaniam
Journal:  Cureus       Date:  2022-05-27

Review 6.  Comprehending the crosstalk between Notch, Wnt and Hedgehog signaling pathways in oral squamous cell carcinoma - clinical implications.

Authors:  Anjali P Patni; M K Harishankar; Joel P Joseph; Bhuvanadas Sreeshma; Rama Jayaraj; Arikketh Devi
Journal:  Cell Oncol (Dordr)       Date:  2021-03-11       Impact factor: 6.730

7.  A Combined Prediction Model for Lymph Node Metastasis Based on a Molecular Panel and Clinicopathological Factors in Oral Squamous Cell Carcinoma.

Authors:  Shu Wang; Tiancheng Li; Huan Liu; Wei Wei; Yang Yang; Chong Wang; Bo Li; Zhengxue Han; Zhien Feng
Journal:  Front Oncol       Date:  2021-04-22       Impact factor: 6.244

8.  LKB-1 Expression and High-Risk Histopathology are Independent Prognostic Factors for Patients with Oral Cavity Carcinoma.

Authors:  José F Carrillo; Christian Cruz-Romero; Alejandro Avilés-Salas; Liliana C Carrillo; Margarita C Ramírez-Ortega; Roberto Herrera-Goepfert; Rafael Vázquez-Romo; Gabriela Figueroa-González; Javier I Altamirano-García; Luis F Oñate-Ocaña
Journal:  Ann Surg Oncol       Date:  2022-03-23       Impact factor: 5.344

9.  Novel pathological predictive factors for extranodal extension in oral squamous cell carcinoma: a retrospective cohort study based on tumor budding, desmoplastic reaction, tumor-infiltrating lymphocytes, and depth of invasion.

Authors:  Yuri Noda; Mitsuaki Ishida; Yasuhiro Ueno; Takuo Fujisawa; Hiroshi Iwai; Koji Tsuta
Journal:  BMC Cancer       Date:  2022-04-13       Impact factor: 4.430

10.  Levofloxacin might be safe to use for OSCC patients.

Authors:  Levent Aydemir; Elif Sinem Iplik; Baris Ertugrul; Goksu Kasarci; Merve Nur Atas; Murat Ulusan; Arzu Ergen; Bedia Cakmakoglu
Journal:  Med Oncol       Date:  2021-06-25       Impact factor: 3.064

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.